Varun Khurana,Tushar Hingorani,Jack Martin Lipman,Kumaresh Soppimath
申请号：
US16644022
公开号：
US20200246294A1
申请日:
2018.09.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Fixed-dose combination drugs comprising an NSAID as a first drug component and a GABA-type calcium channel blocker as a second drug component are contemplated. Further contemplated aspects also include methods of administration of combination drugs and drugs contained herein.
